Long-term chronic baroreflex activation: Persistent efficacy in patients with heart failure and reduced ejection fraction

Journal of Hypertension

Volumn 33, Issue 8, 2015, Pages 1704-1708

  Gronda, Edoardo ^a   Seravalle, Gino ^b   Trevano, Fosca Quarti ^b   Costantino, Giuseppe ^a   Casini, Andrea ^a   Alsheraei, Ali ^a   Lovett, Eric G ^c   Vanoli, Emilio ^a,d   Mancia, Giuseppe ^b   Grassi, Guido ^a,b  

^a IRCCS MULTIMEDICA   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c CVRX INC   (United States)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

autonomic nervous system; baroreflex; heart failure

Indexed keywords

ARTICLE; BAROREFLEX ACTIVATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ARTICLE; COHORT ANALYSIS; CONGESTIVE CARDIOMYOPATHY; ECHOCARDIOGRAPHY; FOLLOW UP; FUNCTIONAL STATUS; HEART FAILURE; HEART FAILURE WITH REDUCED EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; MUSCLE SYMPATHETIC NERVE ACTIVITY; NEW YORK HEART ASSOCIATION CLASS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; QRS INTERVAL; QUALITY OF LIFE; SYMPATHETIC NERVE; SYMPATHETIC TONE; ADRENERGIC SYSTEM; AGED; CLINICAL TRIAL; ELECTROSTIMULATION THERAPY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME;

AGED; BAROREFLEX; ELECTRIC STIMULATION THERAPY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; STROKE VOLUME; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84941216415     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000603     Document Type: Article

References (16)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics -2014 update: a report from the American Heart Association. Circulation 2014; 129: e28-e292
2. La Rovere MT, Pinna GD, Maestri R, Robbi E, Caporotondi A, Guazzotti G, et al. Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era. J Am Coll Cardiol 2009; 53: 193-199
3. Heusser K, Tank J, Engeli S, Diedrich A, Menne J, Eckert S, et al. Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension 2010; 55: 619-626
4. Burgoyne S, Georgakopoulos D, Belenkie I, Tyberg JV. Systemic vascular effects of acute electrical baroreflex stimulation. Am J Physiol Heart Circ Physiol 2014; 307: H236-H241
5. Bisognano JD, Bakris G, Nadim MK, Sanchez L, Kroon AA, Schafer J, et al. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J Am Coll Cardiol 2011; 58: 765-773
6. Bakris GL, Nadim MK, Haller H, Lovett EG, Schafer JE, Bisognano JD. Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial. J Am Soc Hypertens 2012; 6: 152-158
7. Hoppe UC, Brandt MC, Wachter R, Beige J, Rump LC, Kroon AA, et al. Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial. J Am Soc Hypertens 2012; 6: 270-276
8. Brandt MC, Madershahian N, Velden R, Hoppe UC. Baroreflex activation as a novel therapeutic strategy for diastolic heart failure. Clin Res Cardiol 2011; 100: 249-251
9. Gronda E, Seravalle G, Brambilla G, Costantino G, Casini A, Alsheraei A, et al. Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study. Eur J Heart Fail 2014; 16: 977-983
10. Kienbaum P, Peters J. Muscle sympathetic baroreflex sensitivity is different at rest and during evoked hypotension. Basic Res Cardiol 2004; 99: 152-158
11. Grassi G, Seravalle G, Cattaneo BM, Lanfranchi A, Vailati S, Giannattasio C, et al. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation 1995; 92: 3206-3211
12. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311: 819-823
13. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation 1990; 82: 1730-1736
14. Dehlin HM, Levick SP. Substance P in heart failure: the good and the bad. Int J Cardiol 2014; 170: 270-277
15. Shanks J, Herring N. Peripheral cardiac sympathetic hyperactivity in cardiovascular disease: role of neuropeptides. Am J Physiol Regul Integr Comp Physiol 2013; 305: R1411-R1420
16. Abboud FM, Harwani SC, Chapleau MW. Autonomic neural regulation of the immune system: implications for hypertension and cardiovascular disease. Hypertension 2012; 59: 755-762